Navigation Links
Sunesis Pharmaceuticals to Present Data at the Annual Meeting of,the American Association for Cancer Research

is is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies.

Forward-Looking Statements

This press release may contain forward-looking statements that involve substantial risks and uncertainties. Sunesis may not actually achieve the plans, intentions or expectations contained in such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations contained in such forward-looking statements. Sunesis does not assume any obligation to update any such forward-looking statements. For further information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

CONTACT: investors, Eric Bjerkholt, SVP, Corporate Development & Financeof Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or media, MichelleCorral, +1-415-794-8662, or Karen L. Bergman, +1-650-575-1509, both of BCCPartners, for Sunesis Pharmaceuticals, Inc.

Web site: http://www.sunesis.com/

Ticker Symbol: (NASDAQ-NMS:SNSS)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
3. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
4. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
5. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
(Date:12/4/2009)... Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. ... of the American Red Cross are hard at work ... they endure that could potentially put Philadelphia,s blood supply ... strike and set up a picket line yesterday when ...
(Date:12/4/2009)... Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... teleconference and webcast. Principal investigators will discuss the ... myeloma, as featured at the 51st American Society of ... at 9:00 a.m. CT/10:00 a.m. ET on Monday, December ...
(Date:12/4/2009)... CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ... to provide therapy equipment and rehab supplies to Benchmark ... Georgia. ,, "We are pleased to be named ... K. Beardall, executive vice president of sales and marketing ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 1U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 2U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 3U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 4DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 1SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 2SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 3SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 4
... NicOx S.A.,(Euronext Paris: COX) today announced its financial ... during the year. NicOx also,announced today the initiation of ... (see separate press release)., Key highlights 2007:, ... 3 trials for naproxcinod (the ...
... ROCKVILLE, Md., Feb. 29 A study ... genetic variation in the,Ciliary Neurotrophic Factor gene ... study, conducted by Vanda Pharmaceuticals,Inc., included patients ... either with Fiapta(TM) (iloperidone), a novel atypical,antipsychotic ...
Other Medicine Technology:Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 2Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 3Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 4Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 5Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 6Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 7Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 8Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 9Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 10Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 11Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 12Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 13Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 14Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 15Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 2Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 3
(Date:12/7/2009)... estimate their 2009 tax return by using the free tax calculator. Answer simple ... ... 2009 -- Taxpayers can estimate their 2009 tax return by using the free ... a child could understand it. No more waiting or worrying about how much ... a handy tool everyone can use., , , Find out right now ...
(Date:12/7/2009)... more emotional and behavioral difficulties when compared to other ... most when a parent is deployed overseas, according to ... having a parent deployed for a longer period of ... with emotional problems were important factors associated with whether ... published online by the journal Pediatrics . , ...
(Date:12/6/2009)... Calif., Dec. 6 Pharmacyclics, Inc. (Nasdaq: ... a Phase I/II study showing safety and clinical ... Lymphoma (NHL) treated with its HDAC inhibitor PCI-24781 ... today at the 51st ASH Annual Meeting being ... ,, PCI-24781 is an oral pan-HDAC inhibitor ...
(Date:12/6/2009)... treatments targeting growth factor, researchers say , , SUNDAY, ... cancer cells from the main tumor to other parts ... known as TGFb, which may prove a promising target ... researchers say. , Previous studies have shown that TGFb ... movement. In this new study, a team from Cancer ...
(Date:12/6/2009)... 6 Sickle cell disease, a condition ... is one of the most common genetic blood ... including more than 70,000 Americans.(1) Research presented today ... Society of Hematology highlights intriguing studies on the ... children with this blood disorder, evaluations of both ...
Breaking Medicine News(10 mins):Health News:2009 Free Tax Return Calculator 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Breast Cancer's Spread Now Better Understood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9
... having a tough time with jail inmates who are poking ... , with ex- beau Rick Salomon. ,A fellow ... saying 'Paris sure knows how to do hard time, we've ... said that prisoners were constantly taunting a sobbing Hilton by ...
... even at the cost of lives, are turning out to ... are far less likely than whites to get specialized ... leave them more vulnerable to future fatal attacks. ... American Medical Association, tracked 1.2 million Medicare patients at least ...
... has helped thousands of disabled worldwide to walk again, is ... foreign soil . ,The Colombian government has sanctioned the ... limb, to set up base in the South American country. ... NGO. ,M.K. Mathur of BMVSS told IANS: "The ...
... shown a significant increase in Northern Ireland since the early ... living in more affluent areas . The study also revealed ... disease. ,Researchers, who looked at official cancer statistics ... 20 per cent increase in patients and a 62 per ...
... that what I "thought" to be a cold was a bronchial ... could wind up in the hospital . But then a good ... because I have life insurance, only I just can't afford to ... the over inflated prices of medical care and prescription medications. I ...
... emphasised the safety and efficacy of Enbrel (etanercept) in ... ,Biologics, such as etanercept, work by blocking ... body called tumour necrosis factor that is involved in ... as an anti-TNF therapy, etanercept has shown to halt ...
Other Medicine News:Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2Health News:Jaipur Foot All Set to Launch Its Centre in Columbia 2Health News:Deadly Skin Cancer Bites the Rich Harder 2Health News:Deadly Skin Cancer Bites the Rich Harder 3Health News:Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore 2Health News:Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis 2
Shoulder rasp...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
... allows braided suture to be used in ... may be used with any type or ... with anchors or screws (including suture pre-assembled ... Relay can be passed through any conventional ...
Medicine Products: